Science Explorer Interactive view Map
Company · Laval · Canada

Vertex Pharmaceuticals (Canada)

vpharm.comROR OpenAlex
Research works
20
▼ 76% vs 2013–17
Citations
418
20.9 per fractional work
Top-10% rate
7.2%
record average 16.5%
Open access
56%
world 28%

Not ranked overall: Vertex Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Vertex Pharmaceuticals (Canada) publish most on?

By volume in 2022–2025: Cardiac Arrhythmias and Treatments, Cardiac electrophysiology and arrhythmias, Atrial Fibrillation Management and Outcomes and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.

Cardiac Arrhythmias and …1Cardiac Arrhythmias and Treatments: 1 fractional worksCardiac electrophysiolog…1Cardiac electrophysiology and arrhythmias: 1 fractional worksAtrial Fibrillation Mana…0Atrial Fibrillation Management and Outcomes: 0 fractional worksInterstitial Lung Diseas…0Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional worksAntibiotics Pharmacokinetics and Efficacy: 0 fractional worksProtein Structure and Dynamics: 0 fractional worksEnzyme Structure and Function: 0 fractional worksCardiovascular Syncope and Autonomic Disorders: 0 fractional worksMetabolomics and Mass Spectrometry Studies: 0 fractional works
Cardiology and Cardiovascular MedicinePulmonary and Respiratory MedicinePharmacologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cardiac Arrhythmias and Treatments Cardiology and Cardiovascular Medicine 1 works
  2. 2 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 1 works
  3. 3 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  4. 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  5. 5 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  6. 6 Protein Structure and Dynamics Molecular Biology 0 works
  7. 7 Enzyme Structure and Function Materials Chemistry 0 works
  8. 8 Cardiovascular Syncope and Autonomic Disorders Surgery 0 works
  9. 9 Metabolomics and Mass Spectrometry Studies Molecular Biology 0 works
  10. 10 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.7%not open44.3%

World: 28% of research is openly available.

with international co-authors54.7%domestic only45.3%

World: 19% is written across borders.

How has Vertex Pharmaceuticals (Canada)'s research output changed?

Output in 2018–2022 was 76% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Laval

All research institutions in Laval

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.